Beacon Pharmaceuticals PLC (DSE: BEACONPHAR)

Beacon Pharmaceuticals Revenue

Beacon Pharmaceuticals had revenue of 2.80B BDT in the quarter ending September 30, 2024, with 29.95% growth. In the fiscal year ending June 30, 2023, Beacon Pharmaceuticals had annual revenue of 8.51B with 6.07% growth.

• Revenue: 8.51B
• Revenue Growth: +6.07%
• P/S Ratio: n/a
• Revenue / Employee: n/a
• Employees: 3,872
• Market Cap: 30.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	8.51B	487.21M	6.07%
Jun 30, 2022	8.02B	901.58M	12.66%
Jun 30, 2021	7.12B	1.53B	27.37%
Jun 30, 2020	5.59B	943.92M	20.31%
Jun 30, 2019	4.65B	886.08M	23.56%